AASS Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 102.1 kDa
Observed band Not reported — verify product WB image
Gel 8-10%
Positive control ⓘ Lung
Negative control ⓘ Soft tissue
Important caveats
Reasons your observed band may differ from the expected size.
ⓘCalculated mass102.1 kDa
ⓘLocalizationMitochondrion
ⓘProcessing / PTMRecord-dependent
ⓘReactivityHuman / Mouse / Rat

Sample controls for AASS Western blot

🧪Use Lung as the first positive-control candidate and Soft tissue as the HPA Not detected negative candidate.
Positive control: Lung (High)
Negative control: Soft tissue (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for AASS

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart on each tissue page — click any row's HPA link to view the source.

Positive expression · recommended positive controls

Tissue Cell type Level Evidence Source
Lung Reported tissue cells High Protein (HPA) HPA →
Liver Reported tissue cells High Protein (HPA) HPA →
Kidney Reported tissue cells High Protein (HPA) HPA →
Appendix Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

Tissue Cell type Level Evidence Source
Soft tissue Reported tissue cells Not detected Protein (HPA) HPA →
Colon Reported tissue cells Not detected Protein (HPA) HPA →
Section 1

What Is the Expected AASS Western Blot Band Size?

Use the product-observed 102.1 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
102.1 kDaMatches the authoritative product WB observation.
102.1 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected AASS appearancePlan around 102.1 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band102.1 kDa; use this as the primary experimental expectation.
Calculated mass102.1 kDa from UniProt Q9UDR5; retain as context.
Gel selection8-10%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A07302-3.
Why is my band missing or off?
SituationLikely causeNext action
102.1 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.
Section 2

Real Curated AASS Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAppendix
Gel %8-10%
Load20-30 µg total protein per lane
TransferWet/tank, extended transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA07302-3 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 4

Advanced AASS Western Blot Tips

Deeper troubleshooting and optimisation questions for AASS, answered from its protein features.

Which band should guide the blot?
Use 102.1 kDa, the observation attached to the authoritative A07302-3 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 102.1 kDa expectation.
Which positive control should I start with?
Start with Lung, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Soft tissue as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 8-10% consistently across the quick facts, protocol table, and poster.
What transfer method to use for AASS Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A07302-3 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
Compare only the supplied target-verified records: PMC12554910, PMC10676743, PMC6363459.
Boster reagents

AASS Western Blot Reagents

Human/Mouse/Rat-reactive AASS Western blot reagents with authoritative product imagery.

Real WB dataWestern blot validation image for AASS using A07302-3; observed band 102.1 kDa
Anti-AASS Antibody Picoband®
Cat # A07302-3
Reactivity: Human, Mouse, Rat

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.